Cellestia is a clinical-stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus.

Pharmaceutical

Cellestia Biotech

Rajwinder Lehal

Silvio Inderbitzin

Robert Karsunky

Maria Bobadilla

Gaudenz Von Capeller

The Advisory Team at Cellestia Biotech provides strategic guidance and expertise to support the development of innovative therapies. Comprised of industry experts, this team advises on clinical strategy, regulatory pathways, and potential market opportunities to ensure the successful advancement of Cellestia's R&D efforts.

Advisory Team

About

Team members

Other teams at Cellestia Biotech

Leadership Team